Kagoya Y - Search Results

1

BAALC potentiates oncogenic ERK pathway through interactions with MEKK1 and KLF4.

Morita K, Masamoto Y, Kataoka K, Koya J, Kagoya Y, Yashiroda H, Sato T, Murata S, Kurokawa M. Morita K, et al. Among authors: kagoya y. Leukemia. 2015 Nov;29(11):2248-56. doi: 10.1038/leu.2015.137. Epub 2015 Jun 8. Leukemia. 2015. PMID: 26050649

2

Pretransplant predictors and posttransplant sequels of acute kidney injury after allogeneic stem cell transplantation.

Kagoya Y, Kataoka K, Nannya Y, Kurokawa M. Kagoya Y, et al. Biol Blood Marrow Transplant. 2011 Mar;17(3):394-400. doi: 10.1016/j.bbmt.2010.07.010. Epub 2010 Jul 22. Biol Blood Marrow Transplant. 2011. PMID: 20655388 Free article.

3

Hyperbilirubinemia after hematopoietic stem cell transplantation: comparison of clinical and pathologic findings in 41 autopsied cases.

Kagoya Y, Takahashi T, Nannya Y, Shinozaki A, Ota S, Fukayama M, Kurokawa M. Kagoya Y, et al. Clin Transplant. 2011 Sep-Oct;25(5):E552-7. doi: 10.1111/j.1399-0012.2011.01498.x. Epub 2011 Sep 15. Clin Transplant. 2011. PMID: 21919962

4

Hyperlipidemia after allogeneic stem cell transplantation: prevalence, risk factors, and impact on prognosis.

Kagoya Y, Seo S, Nannya Y, Kurokawa M. Kagoya Y, et al. Clin Transplant. 2012 Mar-Apr;26(2):E168-75. doi: 10.1111/j.1399-0012.2012.01628.x. Clin Transplant. 2012. PMID: 22507357

5

Thalidomide maintenance therapy for patients with multiple myeloma: meta-analysis.

Kagoya Y, Nannya Y, Kurokawa M. Kagoya Y, et al. Leuk Res. 2012 Aug;36(8):1016-21. doi: 10.1016/j.leukres.2012.04.001. Epub 2012 May 10. Leuk Res. 2012. PMID: 22579366

6

Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity.

Kagoya Y, Yoshimi A, Kataoka K, Nakagawa M, Kumano K, Arai S, Kobayashi H, Saito T, Iwakura Y, Kurokawa M. Kagoya Y, et al. J Clin Invest. 2014 Feb;124(2):528-42. doi: 10.1172/JCI68101. Epub 2014 Jan 2. J Clin Invest. 2014. PMID: 24382349 Free PMC article.

7

Single-cell gene expression analysis reveals clonal architecture of blast-phase chronic myeloid leukaemia.

Nukina A, Kagoya Y, Watanabe-Okochi N, Arai S, Ueda K, Yoshimi A, Nannya Y, Kurokawa M. Nukina A, et al. Among authors: kagoya y. Br J Haematol. 2014 May;165(3):414-6. doi: 10.1111/bjh.12726. Epub 2014 Jan 8. Br J Haematol. 2014. PMID: 24401018 Free article. No abstract available.

8

Inhibition of histone methyltransferase EZH2 depletes leukemia stem cell of mixed lineage leukemia fusion leukemia through upregulation of p16.

Ueda K, Yoshimi A, Kagoya Y, Nishikawa S, Marquez VE, Nakagawa M, Kurokawa M. Ueda K, et al. Among authors: kagoya y. Cancer Sci. 2014 May;105(5):512-9. doi: 10.1111/cas.12386. Epub 2014 Mar 30. Cancer Sci. 2014. PMID: 24612037 Free PMC article.

9

Evi1 defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemia.

Sato T, Goyama S, Kataoka K, Nasu R, Tsuruta-Kishino T, Kagoya Y, Nukina A, Kumagai K, Kubota N, Nakagawa M, Arai S, Yoshimi A, Honda H, Kadowaki T, Kurokawa M. Sato T, et al. Among authors: kagoya y. Oncogene. 2014 Oct 16;33(42):5028-38. doi: 10.1038/onc.2014.108. Epub 2014 Apr 21. Oncogene. 2014. PMID: 24747972 Free PMC article.

10

Gene expression profiles of central nervous system lymphoma predict poor survival in patients with diffuse large B-cell lymphoma.

Kagoya Y, Nannya Y, Nakamura F, Kurokawa M. Kagoya Y, et al. Br J Haematol. 2014 Sep;166(5):794-7. doi: 10.1111/bjh.12902. Epub 2014 Apr 21. Br J Haematol. 2014. PMID: 24749697 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters